A recent ruling by British Columbia's human rights tribunal has mandated that the private laboratory provider LifeLabs, along with its subsidiary Excelleris Technologies, must pay $32,000 in damages for discriminating against transgender and non-binary patients. This ruling is a significant step in affirming the rights of gender-diverse individuals within healthcare settings.

The tribunal's findings indicate that in 2019, LifeLabs misgendered and outed three patients at its clinics located in Vancouver and Burnaby. One particularly alarming case involved a non-binary individual who was compelled to choose between male or female designations in order to access lab services. Additionally, this person was outed to other patients when they were required to discuss their gender identity in a public area, highlighting the inadequate privacy measures in place.

Another transgender patient faced challenges when attempting to update their gender marker in medical records, ultimately contributing to their distress. A third patient experienced misgendering on lab reports, prompting them to forgo essential cancer screening altogether to avoid further humiliation and misgendering situations.

The tribunal heard from an expert who testified that gender-diverse individuals frequently encounter obstacles when accessing healthcare. Misgendering, in particular, was noted as a "significant source of distress," emphasizing the psychological impact that improper identification can have on transgender and non-binary individuals seeking medical care.

In her ruling, tribunal member Theressa Etmanski mandated that LifeLabs must revise its policies and improve staff training regarding gender identity. Furthermore, the tribunal emphasized the necessity for the availability of private spaces for transgender and non-binary patients to discuss their identity without fear of being outed or misgendered.

Etmanski clarified in the decision, issued on October 29, 2026, that while information about a patient's sex might be medically relevant in providing laboratory services, the evidence presented did not substantiate that maintaining a binary distinction (male or female) was medically necessary or justified.

This landmark ruling places a spotlight on the importance of inclusive practices in healthcare environments, particularly regarding the treatment of transgender and non-binary individuals. By requiring LifeLabs to amend its procedures and enhance staff training, the tribunal aims to foster a more respectful and accessible healthcare experience for all patients, regardless of their gender identity.